Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pre-Operative Cardiac Sonography May Predict Outcomes

By HospiMedica International staff writers
Posted on 03 Aug 2016
A new study suggests that a simple pre-operative echocardiographic assessment of left ventricular (LV) torsion could predict the outcomes of mitral valve surgery.

Researchers at Hayama Heart Center (Kanagawa, Japan) examined 50 consecutive patients with nonischemic, chronic, secondary severe mitral regurgitation (NICSMR). More...
All patients had advanced heart failure (HF) symptoms, and had received the maximum guideline-directed medical therapy for more than six months. The patients were divided into three groups: preserved LV torsion, lost LV torsion, or patients with a wide QRS who received cardiac resynchronization therapy (CRT). All patients received either mitral valve repair or mitral valve replacement.

Two years after surgery, 19 of the patients had died. The researchers found that LV torsional profile predicted post-surgical outcomes in NICSMR patients with a narrow QRS band, but not in those with a wide QRS band. Patients who received CRT prior to mitral surgery showed significantly worse two-year survival than those who received the procedure during mitral surgery. However, the two groups had similar LV torsion. The study was published on June 27, 2016, in JACC: Basic to Translational Science.

“These findings show that lost left ventricular torsion and previously administered cardiac resynchronization therapy appear to be markers of poor survival after mitral surgery in patients with NICSMR,” said lead author Yuichi Notomi, MD, of the division of cardiovascular imaging. “We also found that reverse remodeling was only observed in patients with preserved left ventricular torsion, demonstrating that lost left ventricular torsion and wide QRS were markers of no reverse remodeling viability.”

“Mechanistically, this study suggests that the loss of torsion in patients with heart failure may reflect irreversible structural damage to the heart which would prevent the heart from recovering after corrective surgery,” said Douglas Mann, MD, editor-in-chief of JACC: Basic to Translational Science. “If correct, this will have much broader implications than improvement after mitral valve surgery, since it may predict which patients with heart failure may get better on medications.”

Related Links:
Hayama Heart Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.